Finnrick - Ensuring a Safer and More Transparent Supply Chain
Quenna PMQ

Quenna PMQ
Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP agonist) from Quenna PMQ between 16 Jul 2025 and 13 Dec 2025. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
C
OKAY
Quenna PMQ
Tirzepatide
Tested 6 Samples
Last test 13 Dec 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from Quenna PMQ

Samples are tested in commercial labs

Tests Count

6

Scores

AVG7.0MIN4.7MAX9.0

Last

13 Dec 2025

First

16 Jul 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
13 Dec 2025View4.760mg67.8mg+13.0%99.40%(no batch ID)No Label / Copper Crimp / Clear CapLab GPublic
6 Dec 2025
View8.030mg31.1mg+3.7%99.95%(no batch ID)No Label / Silver Crimp / Clear Teal CapLab EPublic
18 Nov 2025View9.060mg58.6mg-2.3%99.50%Jan 13, 2025No Label / Silver Crimp / Orange CapLab EPublic
1 Oct 2025View4.920mg23.8mg+19.0%99.80%(no batch ID)(no data)Lab GPublic
5 Aug 2025View7.230mg31.14mg+3.8%99.56%(no batch ID)(no data)Lab DPublic
16 Jul 2025View8.040mg39.4mg-1.5%99.97%(no batch ID)White Label / Silver Crimp / Green CapLab EPublic

Corrections

26 Dec 2025
Submitter indicated having swapped vendor identification with sample yauaeu5. This should be Quenna PMQ instead of OUPeptide. Evidence under review, ratings might be updated.